<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">




PREVIOUS INVESTOR AND PHARMA ATTENDEES

DOWNLOAD THE 2018 BROCHURE
ENQUIRE HERE
As well as local and international VCs, CVC, private equity and asset management firms and institutional investors listed below, LSX Nordic Congress convened a selection of family office and high quality and profile retail investors who invest in life science companies on the public markets, brought in partnership with BioStock.


sample-1

Radforsk

HealthCap

HealthCap

L1 Capital

L1 Capital

Norrlandsfonden

Norrlandsfonden

Arix Bioscience

Arix Bioscience

Pfizer

PFIZER

Arctic Fund Management

Arctic Fund Management

Novo Holdings

Novo Holdings

Industrifonden

Industrifonden

EQT

EQT Partners

Investinor

Investinor

BioSeed Capital

BioSeed Capital

Hadean Ventures

Hadean Ventures

Novo Nordisk

Novo Nordisk

sample-1

ReAya Holding

AstraZeneca

AstraZeneca

Ventac Partners

Ventac Partners

Sarsia Seed

Sarsia Seed Management AS

Karolinska Development

Karolinska Development

Advent International

Advent International

PAI Partners

PAI Partners

SECTOR ASSET MANAGEMENT

SECTOR ASSET MANAGEMENT

Kreos Capital

Kreos Capital

M Ventures

M Ventures

GrayBella Capital

GrayBella Capital

Sunstone Life Science Ventures

Sunstone Life Science Ventures

Ruffena Capital

Ruffena Capital

Cascara Ventures

Cascara Ventures

GLOBAL CORE MEDICAL

GLOBAL CORE MEDICAL

Swedbank Robur

Swedbank Robur

Serendipity Partners

Serendipity Partners

TVM CAPITAL

TVM CAPITAL

Xeraya Capital

Xeraya Capital

IPF Partners

IPF Partners

ARTERIAL CAPITAL MANAGEMENT

ARTERIAL CAPITAL MANAGEMENT

TRITON INVESTMENTS ADVISERS

TRITON INVESTMENTS ADVISERS